Authors . | Patients . | Study design . | Adjusted risk . |
---|---|---|---|
Ischaemic heart disease | |||
Al-Ruzzeh et al. [62] | 437 CABG | Cross-sectional | ORs: 2.3–5.5 |
Denollet et al. [63] | 319 CAD | Prospective | OR: 2.2 |
Pedersen et al. [70] | 692 PCI/SES | Prospective | ORs 1.60–3.99; PF: ns |
Pelle et al. [101] | 368 CAD/CR | Prospective | Independent predictor (p = 0.001) |
Chronic heart failure | |||
Schiffer et al. [64] | 84 CHF | Cross-sectional | OR: 3.3 |
Schiffer et al. [61] | 166 CHF | Prospective | ORs: 3.4-6.0; physical dimensions: ns |
Heart transplantation | |||
Pedersen et al. [65] | 186 HTX | Cross-sectional | ORs: 3.5–6.1; BP and GH: ns |
Implantable cardioverter defibrillator | |||
Pedersen et al. [66] | 154 ICD | Prospective | Independent predictor (p <0.001) |
Peripheral arterial disease | |||
Aquarius et al. [67] | 150 PAD; 150 controls | Case–control | OR: 7.4 (overall QoL) |
Aquarius et al. [68] | 150 PAD | Prospective | ORs: 3.9–8.6 |
Aquarius et al. [69] | 203 PAD | Prospective | ORs: 3.7–6.0 |
Authors . | Patients . | Study design . | Adjusted risk . |
---|---|---|---|
Ischaemic heart disease | |||
Al-Ruzzeh et al. [62] | 437 CABG | Cross-sectional | ORs: 2.3–5.5 |
Denollet et al. [63] | 319 CAD | Prospective | OR: 2.2 |
Pedersen et al. [70] | 692 PCI/SES | Prospective | ORs 1.60–3.99; PF: ns |
Pelle et al. [101] | 368 CAD/CR | Prospective | Independent predictor (p = 0.001) |
Chronic heart failure | |||
Schiffer et al. [64] | 84 CHF | Cross-sectional | OR: 3.3 |
Schiffer et al. [61] | 166 CHF | Prospective | ORs: 3.4-6.0; physical dimensions: ns |
Heart transplantation | |||
Pedersen et al. [65] | 186 HTX | Cross-sectional | ORs: 3.5–6.1; BP and GH: ns |
Implantable cardioverter defibrillator | |||
Pedersen et al. [66] | 154 ICD | Prospective | Independent predictor (p <0.001) |
Peripheral arterial disease | |||
Aquarius et al. [67] | 150 PAD; 150 controls | Case–control | OR: 7.4 (overall QoL) |
Aquarius et al. [68] | 150 PAD | Prospective | ORs: 3.9–8.6 |
Aquarius et al. [69] | 203 PAD | Prospective | ORs: 3.7–6.0 |
BP, bodily pain (SF-36); CABG, coronary artery bypass graft surgery; CHF, chronic heart failure; CR, cardiac rehabilitation; GH, general health (SF-36); HTX, heart transplantation; ICD, implantable cardioverter defibrillator; IHD, ischaemic heart disease; NS, not significant; OR, odds ratio; PAD, peripheral arterial disease; PCI, percutaneous coronary intervention; PF, physical functioning (SF-36); QoL, quality of life; SES, sirolimus-eluting stent.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.